Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-09
2006-05-09
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S318000, C546S187000, C546S188000, C546S189000
Reexamination Certificate
active
07041679
ABSTRACT:
The invention relates to crystalline forms of (R)-(+)-N-[[3-[1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl]prop-1-yl]-4-phenylpiperidin-4-yl]-N-methylacetamide and to processes for preparing them.
REFERENCES:
patent: 5741910 (1998-04-01), Bichon et al.
patent: 5942523 (1999-08-01), Bichon et al.
patent: 6040316 (2000-03-01), Chen et al.
patent: 6124316 (2000-09-01), Bichon
patent: 0 673 928 (1995-09-01), None
patent: WO 98/05640 (1998-02-01), None
Rouhi “The right stuff” Chem. Eng. News, p. 32-35, Feb. 24, (2003).
Brittain “Polymorphism in pharmaceutical solids” Marcel Dekker, p. 331-333 (1999).
Rowland et al. “Clinical pharmacokinetics” p. 123 (1995).
Chen, Huai. G. et al., Bioorg. Med. Chem. Lett., (1997), vol. 7, No. 5, pp. 555-560.
Giardina, G.A.M. et al., Bioorg. Med. Chem. Lett., (1996), vol. 6, No. 19, pp. 2307-2310.
Alcade Alain
Anne-Archard Gilles
Gros-Claude Patrick
Monnier Olivier
Roche Jérome
Chang Celia
Gupta Balaram
sanofi-aventis
LandOfFree
Crystalline forms of osanetant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline forms of osanetant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline forms of osanetant will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3546992